Large volumes of multidimensional data are now commonplace in pharmaceutical research. Ability to transform these data into actionable knowledge in a timely manner provides a competitive advantage to organizations that implement smart approaches in data processing, integration, summarization, and democratization.
This presentation explores how the combination of advanced hardware and versatile software are a cornerstone in transforming the way the pharmaceutical industry perceives, processes, and acts upon data.
Yevgeniy Gindin received his PhD in Bioinformatics from Boston University. Currently serving as the Director of Computational Biology & Bioinformatics at Revolution Medicines, Yevgeniy is deeply interested in leveraging computational approaches to uncover hidden patterns in complex datasets.
Allyn graduated from UC San Diego with a MS in Bioengineering in 2021. Allyn is currently serving as a Research Associate at Revolution Medicines where he manages data processing pipelines and tests exploratory techniques for analyzing single cell datasets.
Cecilie Boysen, Ph.D., serves as a Customer Success Director for DNAnexus assisting diagnostic, pharmaceutical, and biotech clients in their efforts to make and use tools to analyze their multi-modality Omics data. Since developing mapping and sequencing technologies instrumental in the first human genome project, she has been developing and applying technologies and software in genomics, functional genomics, immuno-oncology, diagnostics, drug discovery, and bioinformatics. Cecilie holds a Master’s of Science in Biochemistry from University of Copenhagen, Denmark, and a Ph.D. in Biology from Caltech, US.
As head of the client success team at Endpoints News, Kari oversees campaign delivery and strategy for all advertising and client-directed webinars. She brings nearly 20 years of diverse experience across strategic communications, content development and operational leadership.